Rhythm Pharmaceuticals Inc (RYTM) — Quality & forensics
As of 2026-10-28 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 6
- Quality 21
- Growth 72
- Balance sheet 61
- Cash quality 65
- Capital allocation 9
- Momentum 46
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the RYTM chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-28
Quick answers
What is Rhythm Pharmaceuticals Inc's Closelooknet quality reading?
The composite reads 41/100 across 7 modules, as of 2026-10-28: valuation 6, quality 21, growth 72, balance sheet 61, cash quality 65, capital allocation 9, momentum 46. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Rhythm Pharmaceuticals Inc's Altman Z-Score?
13.90, which sits in the safe zone (above 2.99) as of 2026-10-28. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Rhythm Pharmaceuticals Inc's Piotroski F-Score?
5 of 8, as of 2026-10-28. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Rhythm Pharmaceuticals Inc's Beneish M-Score indicate?
-2.88 — below the −1.78 manipulation-risk threshold, as of 2026-10-28. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KOD Kodiak Sciences Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- IOVA Iovance Biotherapeutics Incindustry
- FTRE Fortrea Holdings Inc.industry
- ABSI Absci Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- REPL Replimune Group Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- MRNA Moderna Incindustry
- RXRX Recursion Pharmaceuticals Incindustry
- XNCR Xencor Incindustry
- IRON Disc Medicine Inc.industry
- LEGN Legend Biotech Corpindustry
- BHVN Biohaven Ltd.industry